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Abstract
Introduction
Tuberculosis incidence is disproportionately high among people in poverty. Cash transfer
programs have become an important strategy in Brazil fight inequalities as part of compre-
hensive poverty alleviation policies. This study was aimed at assessing the effect of being a
beneficiary of a governmental cash transfer program on tuberculosis (TB) treatment cure
rates.
Methods
We conducted a longitudinal database study including people�18 years old with confirmed
incident TB in Brazil in 2015. We treated missing data with multiple imputation. Poisson
regression models with robust variance were carried out to assess the effect of TB determi-
nants on cure rates. The average effect of being beneficiary of cash transfer was estimated
by propensity-score matching.
Results
In 2015, 25,084 women and men diagnosed as new tuberculosis case, of whom 1,714
(6.8%) were beneficiaries of a national cash transfer. Among the total population with pul-
monary tuberculosis several determinants were associated with cure rates. However,
among the cash transfer group, this association was vanished in males, blacks, region of
residence, and people not deprived of their freedom and who smoke tobacco. The average
treatment effect of cash transfers on TB cure rates, based on propensity score matching,
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found that being beneficiary of cash transfer improved TB cure rates by 8% [Coefficient 0.08
(95% confidence interval 0.06–0.11) in subjects with pulmonary TB].
Conclusion
Our study suggests that, in Brazil, the effect of cash transfer on the outcome of TB treatment
may be achieved by the indirect effect of other determinants. Also, these results suggest the
direct effect of being beneficiary of cash transfer on improving TB cure rates.
Introduction
Tuberculosis (TB) remains a major health concern and is the leading cause of infectious dis-
ease mortality worldwide [1]. In 2015, there were 10.4 million new TB cases and about 1.4 mil-
lion of deaths, according to the World Health Organization (WHO) estimates. Despite some
improvements, Brazil remains among the highest burden countries in the world with nearly
70,000 incident cases per year [1, 2].
The effect of poverty on TB incidence is unquestionable. The World Health Organization’s
End TB Strategy emphasizes this relationship and supports the integration of social support
policies in a comprehensive approach to TB elimination [3]. The Millennium Development
Goals (MDGs) and, more recently, The Sustainable Development Goals (SDGs) have called
upon governments to combat poverty and its consequences, including health conditions like
TB, in order to enhance global social and economic development [2, 4]. For this reason, cash
transfer programs have become an important strategy to fight inequalities in Brazil. The basic
principle of cash transfer supposes that transfer of cash benefits directly affects poverty and
poverty alleviation for individuals as well as acts indirectly to improve other non-economic
outcomes. As such, cash transfers in Brazil have a place in a comprehensive national social pro-
tection policy [5].
Launched in 2003, the Bolsa Famı´lia Program (BFP) a national conditional cash transfer
program that requires education and health conditionalities to be met by the household for the
receipt of benefits, including school attendance, children’s immunizations, and pre- and post-
natal care [5, 6]. The amount received is the sum of different Bolsa Famı´lia benefits, which
vary according to family composition and income [5, 6]. In addition, the Continuous Cash
Benefit (Benefı´cio de Prestac¸ão Continuada–BPC) is a constitutional right, implemented since
1995, that involves a monthly unconditional cash transfer of a minimum wage (minimum
amount of remuneration that an employer is required to pay wage earners for the work per-
formed during a given period) targeted to people of any age with severe disabilities and to peo-
ple older than 65 years old, who have family per capita income less than one-fourth of the
minimum wage [6].
A systematic review showed that, in low and middle-income countries, effective social sup-
port, through income transfer mechanisms and comprehensive interventions, have beneficial
influences on TB outcomes [7]. The effect of the Brazilian cash transfer programs, specifically,
have been evaluated by several investigators. BFP is associated with improvements in chil-
dren’s educational outcomes [8], parental participations in the labor force [9], childhood mor-
tality [10], and leprosy incidence [11] among other social and health related outcomes. Also,
Family Health Strategy and BFP had a positive impact on the TB mortality rate in Brazil [12].
A recent cohort study of people with TB showed that BFP has a direct effect on improving TB
treatment outcomes [13], in agreement with a previous found from a longitudinal database
study [14].
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In order to understand the role of these governmental benefits on people with TB, since
2014, the Brazilian National Tuberculosis Program requires indication of the BFP beneficiary
status on the TB notification forms. This study was aimed at assessing the effect of being bene-
ficiary of a Brazilian governmental cash transfer program (BFP) on TB treatment cure rates.
Methods
Design and population
We investigated the association between TB determinants and the outcomes of TB treatment
in people from Brazilian Notifiable Disease Information System (SINAN) through a longitudi-
nal database study. We included people�18 years old with confirmed incident TB who started
and finished their treatment in 2015. People with a previous TB treatment were excluded, as
well as those from the state of São Paulo because, in 2015, this state did not incorporate the
new set of SINAN variables including beneficiary status into their surveillance systems.
SINAN is a public database for all notifiable diseases in the Brazilian Unified Healthcare Sys-
tem (SUS–Sistema U´nico de Sau´de). The World Health Organization (WHO) uses SINAN
data in estimating Brazilian TB incidence. These data also include socio-demographic and
clinical characteristics, features of treatment and outcome for individuals diagnosed with TB
[15, 16]. SINAN covers data since the 1990s and is reported to have a high degree of reliability
[16, 17].
Variables
Since 2014, in the beginning of treatment, people diagnosed with TB were asked about their
governmental social programs benefits. A cash transfer beneficiary is considered any house-
hold member in a beneficiary family. These beneficiaries were divided into two groups based
on classification within the SINAN database: a cash transfer group (people who answered as
being beneficiaries of cash transfer program), and a non-cash transfer group (people who
answered as not being beneficiaries of cash transfer program).
Concerning the outcomes of TB treatment, studied participants were prospectively followed
through the treatment, from diagnosis to outcome, with TB outcome categorized as cure,
dropout, death (from TB or from another cause), change of drug regimen, development of
drug-resistant TB, and treatment failure. Cure is defined as treatment success which includes
bacteriologically confirmed cure and completed treatment. The variable ‘treatment outcome’
was dichotomized in ‘cured’ and ‘not cured’ (including all other outcomes).
In order to explore SINAN covariates involved in the causal pathway to determining TB
treatment outcomes, we also assessed the determinants proposed by the theoretical model of
Maciel and Reis-Santos (2015) according to their vulnerability axes [16]. Individual vulnerabil-
ity axis determinants were self-reported during medical evaluation and included: age (<40
years, 40–59 years,�60 years); sex (female, male); years of schooling (no schooling, 1–4 years,
5–8 years, >8 years); skin color/ethnicity (white, black, brown, yellow/indigenous); tobacco
smoking and people with: disorder by alcohol consumption, disorder by illicit drugs use, dia-
betes, mental disorder, and HIV. Variables of social vulnerability axis were also self-reported
and included: place of residence (geographic region: North, Northeast, Middle-West, South-
east, and South); characteristic of area of residence (urban, rural, peri-urban); and the belong-
ing to increased risk populations (deprived of their freedom, homeless, healthcare workers,
and immigrants). Clinical characteristics were also abstracted including the type of TB [pul-
monary, extrapulmonary (EPTB), or pulmonary + EPTB]; and whether people were assigned
to directly observed treatment (DOT) or not. In the Brazilian context, DOT is defined as the
Tuberculosis in Brazil and cash transfer programs
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observation of tuberculosis medicines intake daily, from Monday to Friday, or three times a
week, by a health care professional [18].
Data analysis
Missing data. Missing data are a serious concern in epidemiologic studies, particularly
those using secondary data. SINAN has reasonable completeness as previously reported, but
missing data is a problem for some covariates [17,19]. S1 Table shows that most variables had
more than 80% completeness, however among 25,084 subjects in our sample, only 5,993 (24%)
had completed all information in the dataset. Incomplete datasets can be analyzed using multi-
ple imputation through random draws from distributions inferred from observed data. Multi-
variate imputation by chained equations (MICE) is one of these recommended methods for
multiple imputation in electronic health-record data [20, 21]. We treated missing data by
using an algorithm based on random forest MICE called “missForest”. This algorithm predicts
individual missing values more accurately rather than take random draws from a distribution
and it can be used to impute continuous and/or categorical data including complex interac-
tions and nonlinear relations [22]. Random forest is an extension of classification and regres-
sion trees that uses bootstrap aggregation of multiple regression trees to reduce the risk of
overfitting. It combines the predictions from many trees to produce more accurate predictions
[23]. We choose MICE random forest with 1,000 trees. Evidence has suggested that random
forest MICE produces less biased parameter estimates and confidence interval with better cov-
erage [23]. The imputation analysis was performed using the program R Project, version 3.3.3
(R Group, Vienna Austria).
Assessing the determinants of TB treatment outcome. Poisson regression models with
robust variance were carried out to assess the effect of TB determinants on cure rates in the
whole population and among the cash transfer group [24]. “Not cured” was defined as the ref-
erence category in both analyses. The TB determinants were included in the regression mod-
els, according to the following hierarchical levels: level 1 (sex, age, skin color, and schooling),
level 2 (place of residence and characteristic of area of residence), level 3 (being deprived of
their freedom, living in homeless, healthcare workers, and immigrants), level 4 (tobacco smok-
ing, living with: alcohol use disorder, substance abuse disorder, diabetes, mental health disor-
der, and HIV), and level 5 (DOT or not). Thus, the effect of each determinant on the outcomes
is interpreted as having been adjusted for all the variables that belong to the hierarchical levels
above it (distal), as well as for the determinants’ effects that coexist on the same level [16]. Fur-
thermore, this analysis was performed with participants with all type of TB and was replicated
in a subsample of participants with pulmonary TB only. Since data were provided by a longitu-
dinal database, the estimates were presented as risk ratios (RR) and 95% confidence intervals
(95%CI).
Effect of cash transfer program on TB treatment outcome. People covered by govern-
mental social programs of cash transfer must meet eligibility criteria, including low income
and compliance with conditions related to education and health [25]. However, this govern-
mental benefit is not universal; there are some people who meet these criteria but are not bene-
ficiaries of national cash transfer programs. As SINAN did not incorporate information about
eligibility to social programs, non-beneficiaries of the cash transfer program are a heteroge-
neous group. Therefore, the assessment of effect of being beneficiary of cash transfer program
was performed by using a propensity score approach.
Propensity score indicates the probability of allocation to exposure group given the mea-
sured covariates [26]. The inclusion of people on BFP is not at random and, consequently, a
single evaluation between beneficiaries and non-beneficiaries is not appropriate because the
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effect of BFP could be related to background characteristics, which may be different between
groups. Propensity score matching estimation of the conditional probability of a person being
a beneficiary, according to observed characteristics, and overcoming the selection limitations
[26]. We estimated the propensity score of being beneficiary of cash transfer program using a
logit model. The propensity score model included the following set of variables as predictors:
schooling, area of residence, being healthcare worker, and presence of comorbidities (presence
of one or more of the following comorbidities: tobacco smoking, alcohol use disorder, sub-
stance abuse disorder, diabetes, mental health disorder, and HIV). These variables were
defined a priori based on our previous theoretical model to determine TB treatment outcomes
using a direct acyclic graph (DAG) [13, 16].
We used Poisson regression models with robust variance to evaluate the direct effect of gov-
ernment cash transfer program on TB treatment outcomes (“not cured” was the category of
reference). The first adjusted model included the set of confounding variables to the direct
effect of cash transfer program on the outcomes: schooling, skin color, area of residence,
region of residence, being healthcare worker, and comorbidities. The second model was
adjusted by the propensity score (as continuous variable) and, additionally, by skin color and
region of residence, which were not contained in the propensity score. Again, the Poisson
regression models were replicated in a subsample including only people with pulmonary TB.
The average effect of being beneficiary of cash transfer program was estimated by propen-
sity-score matching in a 1:1 ratio (we consider a pair of observations a match if the absolute
difference in the propensity score was less than 0.05) [27, 28]. In this analysis, the outcomes
were dichotomized as cured versus not cured and repeated for participants with pulmonary
TB. The results were presented as coefficients, which are the difference between the effects for
beneficiaries of cash transfer program compared to non-beneficiaries, and 95%CI. We also
assessed whether assignment to DOT moderated the association of being a beneficiary of cash
transfer program and cure rates of TB treatment.
Sensitivity analyses. In addition, all analyses mentioned above were replicated using a
dataset which included only individuals without any missing SINAN data (so, not subject to
imputation). The results are shown in the supplementary material.
Data were analyzed using Stata 14 (Stata Corp., College Station, USA).
Ethics approval
The study was approved by the ethics committee of Centro de Ciências da Sau´de from Univer-
sidade Federal do Espı´rito Santo under the number 242,826.
Role of the funding source
There was no involvement of the funding source in study design, collection, analysis, and
interpretation of data, writing, or in the decision to submit the paper for publication. All the
authors had full access to the data in the study and had final responsibility for this publication.
Results
In 2015, there were 76,109 people with TB notified in SINAN, of which 46,568 finished their
treatment in the same year. We excluded 14,504 people from São Paulo (without information
about governmental benefits and 6,980< 18 years old and/or with previous TB treatment (Fig
1). Thus, in the present analysis, we included 25,084 women and men aged�18 years old diag-
nosed as new TB case, of whom 1,714 (6.8%) were beneficiaries of governmental social pro-
gram of cash transfer (cash transfer group).
Tuberculosis in Brazil and cash transfer programs
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Sample description
Table 1 shows that 12,911 (51%) and 896 (52%) of whole population and cash transfer group
were<40 years old, respectively. With respect to schooling, 2,405 (10%) of whole population
and 328 (19%) of cash transfer group had no schooling and 7,360 (29%) of whole population
and 598 (35%) of cash transfer group had one to four years of education. 7,405 (30%) of whole
population, excluding all people from São Paulo state, live in the Southeast region while 763
(45%) of cash transfer group live in the Northeast region.
Concerning behaviors and comorbidities (Table 2), among whole population and cash
transfer group, respectively, 4,314 (17%) and 281 (16%) smoked tobacco, 4,314 (17%) and 214
(12%) lived with alcohol use disorder, 2,350 (9%) and 96 (6%) substance abuse disorder, 2,109
(8%) and 165 (10%) lived with diabetes, 609 (2%) and 53 (3%) lived with mental health disor-
der, and 2,815 (11%) and 128 (7%) lived with HIV.
Determinants of TB treatment outcome
The association of TB determinants and treatment outcome is showed in Table 3. Men demon-
strated a lower probability of cure when compared with women (RR 0.90; 95%CI 0.88 to 0.91
Fig 1. Flowchart of study sampling of people from the Brazilian Notifiable Disease Information System database (SINAN), 2015.
https://doi.org/10.1371/journal.pone.0212617.g001
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Table 1. Distribution of sociodemographic determinants of tuberculosis among people from the Brazilian Notifi-
able Disease Information System database (SINAN), 2015.
Determinants Total population Cash transfer group
n % n %
Sex
Women 8,330 33 942 55
Men 16,754 67 772 45
Total 25,084 100 1,714 100
Age
<40 years 12,911 51 896 52
40–59 years 8,066 32 493 29
>60 years 4,107 16 325 19
Total 25,084 100 1,714 100
Schooling
No schooling 2,405 10 328 19
1–4 years 7,360 29 598 35
5–8 years 7,467 30 495 29
>8 years 7,852 31 293 17
Total 25,084 100 1,714 100
Skin color
White 7,832 31 309 18
Black 3,544 14 281 16
Brown 13,164 53 973 57
Yellow/Indigenous 544 2 151 9
Total 25,084 100 1,714 100
Place of residence
North 3,739 15 280 16
Northeast 8,226 33 763 45
Southeast 7,405 30 283 17
South 4,113 16 214 12
Middle-West 1,601 6 174 10
Total 25,084 100 1,714 100
Area of residence
Urban 22,511 90 1,297 76
Rural/peri-urban 2,573 10 417 24
Total 25,084 100 1,714 100
People deprived of their freedom
No 23,185 92 1,624 95
Yes 1,899 8 90 5
Total 25,084 100 1,714 100
Homeless
No 24,555 98 1,697 99
Yes 529 2 17 1
Total 25,084 100 1,714 100
Healthcare worker
No 24,739 99 1,705 99
Yes 345 1 9 1
Total 25,084 100 1,714 100
Immigrant
(Continued)
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in participants with all TB forms and RR 0.90; 95%CI 0.88 to 0.92 in participants with pulmo-
nary TB). However, this difference vanished among men and women in the cash transfer
group (RR 0.97; 95%CI 0.92 to 1.02 for participants with all TB forms and RR 0.98; 95%CI 0.93
to 1.03 for participants with pulmonary TB). When compared with people with no schooling,
the risk ratio for cure was higher for those who studied > 8 years among total population (RR
1.19; 95%CI 1.15 to 1.23 to people with pulmonary TB), but was not seen among cash transfer
group (RR 0.93; 95%CI 0.86 to 1.02 to people with pulmonary TB). Among the regions of Bra-
zil, only people from the Northeast, when compared with those from Southeast, had higher
cure rates (RR 1.12; 95%CI 1.02 to 1.21 in people with pulmonary TB).
Cure rates were inversely associated with homeless status (RR 0.54; 95%CI 0.48 to 0.60 to
participants with all TB forms and RR 0.53; 95%CI 0.47 to 0.60 to participants with pulmonary
TB) among total population. However, among the cash transfer group, this association was not
found (RR 0.73; 95%CI 0.48 to 1.11 for participants with all TB forms and RR 0.68; 95%CI 0.42
to 1.10 for participants with pulmonary TB). Having, alcohol use disorder, drug use disorder,
or living with HIV/AIDS were associated with decreased cure rates in the models analyzed.
People assigned to DOT were more likely to experience TB cure when compared with those
not assigned to DOT in the total studied population (RR 1.21; 95%CI 1.19 to 1.23 in partici-
pants with all TB forms and RR 1.22; 95%CI 1.20 to 1.25 in participants with pulmonary TB).
This effect was sustained among people in the cash transfer group, however there was an atten-
uation in the estimates of effect (RR 1.17; 95%CI 1.10 to 1.24 in participants with all TB forms
and RR 1.15; 95%CI 1.08 to 1.22 in participants with pulmonary TB).
Effect of cash transfer program on TB treatment outcome
Table 4 shows that 68% (15,894) of people without cash transfer benefit were cured, while 78%
(1,331) of people with cash transfer benefit were cured of TB according to our outcome
definitions.
Controlling for confounding variables, there was a positive direct effect of being beneficiary
of cash transfer program on cure rates of TB treatment in Poisson models of both studied
groups, participants with all TB form and participants with pulmonary TB alone (Table 4).
The risk ratio of cure among the cash transfer group was 1.13 (95%CI: 1.10 to 1.16) in both the
model adjusted by confounding variables individually and the propensity scored model. DOT
moderated the effect of this association [RR 1.16 (95%CI, 1.10 to 1.23) among participants
with pulmonary TB not assigned to DOT and RR 1.08 (95%CI, 1.05 to 1.11) among partici-
pants with pulmonary TB assigned to DOT].
The average treatment effect of governmental program of cash transfer on TB cure rates,
based on propensity score matching, found that being beneficiary of cash transfer improved
cure rates by 8% [Coefficient 0.08 (95%CI: 0.05 to 0.10) in participants with TB of any type
and Coefficient 0.08 (95%CI: 0.06 to 0.11) to participants with pulmonary TB only]. Also, the
balance plots showed an improvement in the comparability between cash transfer groups after
matching (Fig 2).
Table 1. (Continued)
Determinants Total population Cash transfer group
n % n %
No 25,003 100 1,710 100
Yes 81 0 4 0
Total 25,084 100 1,714 100
https://doi.org/10.1371/journal.pone.0212617.t001
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Table 2. Distribution of clinical determinants of tuberculosis among people from the Brazilian Notifiable Disease
Information System database (SINAN), 2015.
Determinants Total population Cash transfer group
n % n %
Tobacco smoking
No 20,770 83 1,433 84
Yes 4,314 17 281 16
Total 25,084 100 1,714 100
Alcohol use disorder
No 20,770 83 1,500 88
Yes 4,314 17 214 12
Total 25,084 100 1,714 100
Drug abuse disorder
No 22,734 91 1,618 94
Yes 2,350 9 96 6
Total 25,084 100 1,714 100
Diabetes
No 22,975 92 1,549 90
Yes 2,109 8 165 10
Total 25,084 100 1,714 100
Mental health disorder
No 24,475 98 1,661 97
Yes 609 2 53 3
Total 25,084 100 1,714 100
HIV/AIDS
No 22,269 89 1,586 93
Yes 2,815 11 128 7
Total 25,084 100 1,714 100
Clinical form
Pulmonary 21,163 84 1,504 88
EPTB or pulmonary + EPTB 3,921 16 210 12
Total 25,084 100 1,714 100
DOT
No 12,643 50 578 34
Yes 12,441 50 1,136 66
Total 25,084 100 1,714 100
Cash transfer program
No 23,370 93 0 0
Yes 1,714 7 1,714 100
Total 25,084 100 1,714 100
Treatment outcome
Not cure 7,859 31 383 22
Cured 17,225 69 1,331 78
Total 25,084 100 1,714 100
DOT: directly observed therapy; EPTB: extrapulmonary tuberculosis; HIV/AIDS: human immunodeficiency virus/
acquired immunodeficiency syndrome; n: number of observations; TB: tuberculosis.
https://doi.org/10.1371/journal.pone.0212617.t002
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Table 3. Adjusted� risk ratios of hierarchical Poisson regression models of the association of determinants of TB and treatment cure rates to 25,084 people from
the Brazilian Notifiable Disease Information System database (SINAN), 2015.
Determinants Risk ratios (95% confidence intervals) �
Total population Cash transfer group
All TB forms Pulmonary TB only All TB forms Pulmonary TB only
Level 1
Sex
Male 0.90 (0.88 to 0.91) 0.90 (0.88 to 0.92) 0.97 (0.92 to 1.02) 0.98 (0.93 to 1.03)
Age
40–59 years 0.96 (0.95 to 0.98) 0.98 (0.96 to 1.00) 0.93 (0.87 to 0.98) 0.93 (0.87 to 0.99)
>60 years 0.81 (0.79 to 0.84) 0.82 (0.80 to 0.85) 0.75 (0.68 to 0.82) 0.73 (0.67 to 0.81)
Schooling
1–4 years 1.00 (0.97 to 1.04) 1.01 (0.97 to 1.04) 0.96 (0.90 to 1.03) 0.94 (0.88 to 1.01)
5–8 years 0.91 (0.88 to 0.95) 0.93 (0.90 to 0.97) 0.87 (0.81 to 0.94) 0.87 (0.80 to 0.94)
>8 years 1.17 (1.13 to 1.21) 1.19 (1.15 to 1.23) 0.93 (0.85 to 1.01) 0.93 (0.86 to 1.02)
Skin color
Black 0.94 (0.91 to 0.96) 0.94 (0.91 to 0.97) 0.95 (0.86 to 1.05) 0.98 (0.88 to 1.08)
Brown 0.98 (0.96 to 1.00) 0.99 (0.97 to 1.01) 1.05 (0.98 to 1.13) 1.06 (0.98 to 1.15)
Yellow/Indigenous 1.15 (1.10 to 1.20) 1.15 (1.10 to 1.21) 1.07 (0.97 to 1.18) 1.07 (0.97 to 1.19)
Level 2
Region of residence
North 1.11 (1.08 to 1.14) 1.14 (1.11 to 1.17) 1.05 (0.96 to 1.16) 1.10 (0.99 to 1.21)
Northeast 1.10 (1.08 to 1.13) 1.10 (1.08 to 1.13) 1.08 (0.99 to 1.17) 1.12 (1.02 to 1.21)
Middle-West 1.09 (1.06 to 1.13) 1.11 (1.07 to 1.15) 0.99 (0.87 to 1.12) 0.99 (0.86 to 1.13)
South 0.93 (0.90 to 0.96) 0.95 (0.92 to 0.98) 0.97 (0.86 to 1.08) 0.99 (0.88 to 1.12)
Area of residence
Rural or peri-urban 1.15 (1.12 to 1.18) 1.15 (1.12 to 1.18) 1.14 (1.07 to 1.20) 1.12 (1.06 to 1.19)
Level 3
Deprived of their freedom 1.14 (1.10 to 1.17) 1.14 (1.11 to 1.18) 1.12 (1.04 to 1.22) 1.09 (0.99 to 1.19)
Homeless 0.54 (0.48 to 0.60) 0.53 (0.47 to 0.60) 0.73 (0.48 to 1.11) 0.68 (0.42 to 1.10)
Healthcare worker 0.99 (0.93 to 1.05) 0.94 (0.88 to 1.01) 1.16 (0.86 to 1.58) 1.08 (0.65 to 1.77)
Immigrant 1.09 (0.94 to 1.27) 1.04 (0.87 to 1.24) 1.23 (0.97 to 1.56) 1.32 (0.99 to 1.75)
Level 4
Tobacco smoking 0.93 (0.90 to 0.96) 0.93 (0.90 to 0.96) 0.89 (0.81 to 0.98) 0.91 (0.83 to 1.01)
Alcohol use disorder 0.85 (0.82 to 0.87) 0.84 (0.81 to 0.87) 0.82 (0.73 to 0.91) 0.81 (0.72 to 0.91)
Drug use disorder 0.76 (0.73 to 0.80) 0.77 (0.73 to 0.81) 0.83 (0.69 to 0.99) 0.81 (0.67 to 0.97)
Diabetes 1.01 (0.98 to 1.04) 1.01 (0.98 to 1.04) 0.97 (0.89 to 1.07) 0.98 (0.89 to 1.07)
Mental health disorder 0.98 (0.92 to 1.04) 0.97 (0.90 to 1.03) 1.04 (0.93 to 1.15) 1.07 (0.97 to 1.18)
HIV/AIDS 0.42 (0.40 to 0.44) 0.44 (0.41 to 0.47) 0.46 (0.36 to 0.58) 0.52 (0.41 to 0.66)
Level 5
DOT 1.21 (1.19 to 1.23) 1.22 (1.20 to 1.25) 1.17 (1.10 to 1.24) 1.15 (1.08 to 1.22)
� Adjusted for the determinants that belong to the hierarchical levels above, as well as for the determinants’ effects on the same level.
DOT: directly observed therapy; EPTB: extrapulmonary tuberculosis; HIV/AIDS: human immunodeficiency virus/ acquired immunodeficiency syndrome; n: number of
observations; TB: tuberculosis.
References: treatment outcome (cure), age (<40 years), schooling (no schooling), skin color (white), region of residence (Southeast), area of residence (urban), people
deprived of their freedom (no), people living in homeless (no), healthcare worker (no), immigrant (no), and DOT (no).
https://doi.org/10.1371/journal.pone.0212617.t003
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Sensitivity analyses
All analyses were replicated with a dataset of people without missing information with did not
undergo previous imputation, and they are available as supplementary material (S1, S2, S3 and
S4 Tables and S1 Fig).
Discussion
Determinants of TB treatment outcome
In a Brazilian longitudinal database of people newly diagnosed with TB in 2015, we identified
several determinants of TB treatment outcomes. Among the total population with pulmonary
TB only, males, older subjects, those with 5–8 years of schooling, blacks, those living in the
Southeast and South region and urban areas were less likely to be cured. Also were less likely
to be cured those not deprived of their freedom, homeless, who smoke tobacco, living with
alcohol use disorder, substance abuse or drug abuse disorder, HIV AIDS, and those assigned
to DOT. However, among the cash transfer group, the association disappeared among males,
blacks, region of residence, not deprived of their freedom, and who smoke tobacco products.
Table 4. Distribution and estimates of the direct effect of being beneficiary of governmental cash transfer program on tuberculosis treatment outcomes among peo-
ple from the Brazilian Notifiable Disease Information System database (SINAN), 2015.
Determinants All TB forms Pulmonary TB only
Treatment outcome
Not cured
n (%)
Cured
n (%)
Total
n (%)
Not cured
n (%)
Cured
n (%)
Total
n (%)
No cash transfer group 7,476 (32) 15,894 (68) 23,370 (100) 6,174 (31) 13,485 (69) 19,659 (100)
Cash transfer group 383 (22) 1,331 (78) 1,714 (100) 316 (21) 1,188 (79) 1,504 (100)
Total 7,859 (31) 17,225 (69) 25,084 (100) 6,490 (31) 14,673 (69) 21,163 (100)
Total population
Model Aa RR 1.14 (95%CI, 1.11 to 1.17) RR 1.15 (95%CI, 1.12 to 1.18)
Model Bb RR 1.13 (95%CI, 1.10 to 1.16) RR 1.14 (95%CI, 1.10 to 1.17)
Model Cc RR 1.13 (95%CI, 1.10 to 1.16) RR 1.14 (95%CI, 1.10 to 1.17)
Not assigned to DOT
Model Aa RR 1.11 (95%CI, 1.04 to 1.17) RR 1.15 (95%CI, 1.08 to 1.21)
Model Bb RR 1.13 (95%CI, 1.07 to 1.20) RR 1.16 (95%CI, 1.10 to 1.23)
Model Cc RR 1.12 (95%CI, 1.05 to 1.18) RR 1.15 (95%CI, 1.09 to 1.23)
Assigned to DOT
Model Aa RR 1.10 (95%CI, 1.07 to 1.13) RR 1.10 (95%CI, 1.07 to 1.13)
Model Bb RR 1.08 (95%CI, 1.05 to 1.11) RR 1.08 (95%CI, 1.05 to 1.11)
Model Cc RR 1.09 (95%CI, 1.05 to 1.12) RR 1.09 (95%CI, 1.05 to 1.12)
ATEd total population Coeff. 0.08 (95%IC, 0.05 to 0.10) Coeff. 0.08 (95%IC, 0.06 to 0.11)
ATEd not assigned to DOT Coeff. 0.06 (95%IC, 0.02 to 0.10) Coeff. 0.08 (95%IC, 0.04 to 0.13)
ATEd assigned to DOT Coeff. 0.06 (95%IC, 0.03 to 0.09) Coeff. 0.06 (95%IC, 0.03 to 0.09)
a: Model unadjusted.
b: Model adjusted by schooling, skin color, healthcare worker, area of residence, region of residence, and comorbidities.
c: Model adjusted by propensity score, skin color, and region of residence.
d: Average treatment effect of being beneficiary of governmental social program of cash transfer on cure.
Coeff.: difference of the effects for beneficiaries of cash transfer program and non-beneficiaries; DOT: directly observed therapy; n: number of observations; RR: risk
ratio
Not Cured: reference category of outcome.
https://doi.org/10.1371/journal.pone.0212617.t004
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Previous assessment of SINAN database found similar associations among TB determinants
[16]. New variables such as tobacco smoking, drug or substance use disorder, homeless,
healthcare worker and immigrant status were recently included in the SINAN dataset based
Fig 2. Balance box from propensity score matching of people from the Brazilian Notifiable Disease Information System database (SINAN-2015).
https://doi.org/10.1371/journal.pone.0212617.g002
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on evidence of high vulnerability among these people. Our results reinforce the role of these
determinants in Brazil.
In general, studies evaluating the determinants of TB treatment outcome among beneficia-
ries of cash transfer programs are scarce. Torrens et. al. found, among people who were benefi-
ciaries of BFP during TB treatment and after TB treatment, that cure was less likely in older
subjects, illiterates, blacks, PLHIV/AIDS, those with unknown HIV status, and those not
assigned to DOT [14].
In our present study, the effect of some determinants of TB treatment outcome in the total
population was not maintained in the cash transfer group, suggesting that there might be an
indirect effect of governmental social programs of cash transfer on TB treatment outcome in
agreement with previous evidence [29]. Several mechanisms are pointed out to the potential
impact of such intervention on TB treatment outcome and they include reducing financial
barriers to accessing care and improving health behaviors [30].
Effect of cash transfer program on TB treatment outcome
Our results suggest that there is an independent effect of benefit of cash transfer on improving
cure rates of TB among people under TB treatment. This field of research is still incipient, but
most of the studies evaluated the role of TB-specific initiatives of cash transfer on cure rates
and they also found a positive association [13, 31].
With regard to TB-specific initiative, in Peru, people being treated for TB and their house-
hold contacts were randomly assigned to socioeconomic support (comprised conditional cash
transfers up to $230 United States dollars). The socioeconomic support intervention was feasi-
ble and increased the proportion of household contacts of people being treated for TB who ini-
tiated TB preventive therapy; and the TB treatment success rate among people with TB [32].
To our knowledge, in Brazil, only two previous studies assessed the effect of a TB-sensitive pro-
gram of cash transfer, the BFP, on TB treatment outcome [13, 14]. In the first published study, an
analysis using secondary data, the authors found a positive association between BFP and TB cure
and thus hypothesized an indirect effect of BFP through changes in behaviors and response to
treatment [14]. The second study, based on a cohort of people with TB, estimated the average
effect of being a BFP beneficiary on TB treatment outcomes and observed that the average effect
for cure was 0.076 (IC 95% 0.037–0.116), for default was -0.070 (IC 95% - 0.105 - -0.036) and for
death it was -0.002 (IC 95% - 0.021–0.017) [13]. Based on the same theoretical model to assess the
direct effect of cash transfer, but using a secondary database, our study found similar results.
Catastrophic costs incurred when the total costs due to TB disease exceed 20% of the annual
household income. Thus, social protection initiatives, TB-specific or not, appear to be a way to
struggle against catastrophic costs, by alleviating the heavy economic burden of TB [33]. In
Brazil, one study evaluated costs borne by TB-affected households and the proportion of
households with catastrophic costs. The study evaluated the catastrophic costs in people with
multidrug resistant (MDR) TB in Rio de Janeiro. The proportion ranged from 36% to 61% and
confirmed that the social protection alleviates the catastrophic cost of these people [34].
The consistency between these results strengthens the evidence of a direct effect of BFP on
TB treatment outcomes. However, given the nature of the data, we can not rule out the possi-
bility that residual confounding may act in this association. Effect estimates reported by obser-
vational studies can be distorted by confounding. Generally, measurement error in a
confounder and unmeasured confounders results in partial adjustment, biasing the association
of interest in any direction [35]. The greatest challenges include the evaluations of social and
behavioral determinants, since they involve complex causal chains, different dimensions, non-
specific pathways and weak causal forces [36].
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Directly observed therapy
Evaluation based on the SINAN database with people notified with TB, in 2011, revealed that
the DOT strategy targets vulnerable populations, as it is designed to do, and that it had an
important impact on improving the TB cure rate in these populations [37]. Our results, with
data from 2015, suggest an impact of DOT on TB treatment outcome even higher, suggesting
that the role of DOT should not be disregarded in the struggle for TB control.
In agreement with previous findings [13, 14], our study showed that the direct effect of cash
transfer was moderated by DOT, meaning that people not assigned to DOT had a higher direct
effect of BFP. DOT improves the communication between health services and people with TB
[37] and our hypothesis is that cash transfer benefit also work through this same mechanism.
It is essential, therefore, to take into account that the protective effects of DOT and cash trans-
fer benefit may combine synergistically in people covered by both. Further studies should
assess the intermediate effect of DOT on the association between cash transfer benefit and TB
treatment outcomes aiming at better understanding this relationship and developing the artic-
ulation between both strategies in Brazil.
Strengths and limitations
The strengths of this study include the large longitudinal database with a countrywide sample,
allowing a wide national representativeness. Moreover, we built the analytic models based on a
rigorous theoretical model specific to Brazil and used multiple imputation techniques to deal with
missing data. In spite of the known variation of missing data between states, and geographical
regions, the reasons for such absence are related to health facilities characteristics, leading to a
non-differential measurement error which was dealt with through multiple imputation. In the
present study, we performed a sensitivity analysis to assess the likelihood of bias due to imputation
by replicating our models with a dataset of people with completed information. Results with inclu-
sive confidence intervals allow us to conclude that the main findings are consistent.
While governmental benefit was reported in the same way for beneficiaries and non-benefi-
ciaries, the self-reported information may be a limitation by lowering accuracy and potential
misclassification. As this error is likely to be non-differential, it would leave residual confound-
ing. Heterogeneity among non-beneficiaries of cash transfer program also could be a limita-
tion of our study. To overcome this, we used a propensity score approach to indicate the
probability of allocation to exposure group and control for different variants of exposure. In
addition, the assessments of social and behavioral aspects involve complex causal chains and
contextual effects may also interact with these individuals’ characteristics altering the outcome
determination [36]. Even performing an analysis based on a framework for causal thinking
and adjusting to relevant social and behavioral determinants of health, we believe that residual
confounding by these characteristics could be biasing our results.
DOT should be considered in SINAN as the observation of TB medicines taken, by a health
professional, at least 3 times a week, in the attack phase, and at least 2 times a week, in the
maintenance phase. However, there is no quality control to assure the consistency of this vari-
able and DOT might not be correct classified in some health facilities. In spit of this limitation,
is important to highlight that the initiative which led the health professional to assigned a peo-
ple as under DOT contributed to better treatment outcomes.
Conclusion
Our study suggests that, in Brazil, the effect of benefit of governmental cash transfer on the
outcome of TB treatment may be achieved by other determinants, indirect effect. Also, there is
suggestion of a direct effect of being beneficiary of cash transfer program on improving TB
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cure rates. Further studies should focus on elucidating the social and behavioral determinants
which may play a role in the association of TB-sensitive interventions and the outcome of TB
treatment, as well as on describing all causal paths involved in this association. Also, the effect
of TB-specific interventions on the outcome of TB treatment as well as the role of strategies
like DOT, with recognized effectiveness, in these association should be assessed.
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